Connolly K C, Gabra H, Millwater C J, Taylor K J, Rabiasz G J, Watson J E, Smyth J F, Wyllie A H, Jodrell D I
Imperial Cancer Research Fund Medical Oncology Unit, Western General Hospital, Edinburgh, Scotland, United Kingdom.
Cancer Res. 1999 Jun 15;59(12):2806-9.
Loss of heterozygosity (LOH) at 11q23-qter occurs frequently in ovarian and other cancers, but for colorectal cancer, the evidence is conflicting. Seven polymorphic loci were analyzed between D11S897 and D11S969 in 50 colorectal tumors. Two distinct LOH regions were detected, suggesting possible sites for tumor-suppressor genes involved in colorectal neoplasia: a large centromeric region between D11S897 and D11S925, and a telomeric 4.9-Mb region between D11S912 and D11S969. There was no correlation with clinicopathological features. This analysis describes a region of LOH in the region 11q23.3-24.3 for the first time in colorectal cancer and provides complementary evidence for the ongoing effort to identify the gene(s) involved.
11q23-qter杂合性缺失(LOH)在卵巢癌和其他癌症中频繁发生,但在结直肠癌中,证据存在矛盾。在50例结直肠肿瘤中分析了D11S897和D11S969之间的7个多态性位点。检测到两个不同的LOH区域,提示可能存在参与结直肠癌形成的肿瘤抑制基因位点:一个位于D11S897和D11S925之间的大着丝粒区域,以及一个位于D11S912和D11S969之间的端粒4.9-Mb区域。与临床病理特征无相关性。该分析首次描述了结直肠癌中11q23.3-24.3区域的LOH区域,并为正在进行的鉴定相关基因的努力提供了补充证据。